Gordon Signy Fellowships
The World Pathology Foundation was origionaly chartered in 1972, in Berne, Switzerland. At that time the World Association of Societies in Pathology or WASP, as it was then known, decided that a body, completely separate and independent of the WASP was required. The purpose of this new body was stated thus: " The objectives of the Foundation are scientific, educational and charitable; to promote public safety and public health by fostering the development of good standards in anatomic and clinical pathology, especially in the developing countries." To further these aims, the World Pathology Foundation will, among others, foster research, education and application of these medical sciences by organizing conferences, encouraging interchange of pathology information among nations and initiating and prompting publications in pathology.
Shortly after its founding, the World Pathology Foundation established Gordon Signy Foreign Fellowships in honor of Gordon Signy, a notable supporter of the World Association, who died in London in 1972. He qualified in Medicine at Guy's Hospital, London, in 1926 and became a clinical pathologist in the widest sense, his professional career spanning nearly a half century of astounding advances in all branches of pathology, anatomic and clinical. Over 28 years he established and developing the prestigious (British) Journal of Clinical Pathology. He helped to establish and was a Foundation Vice-President of the Royal College of Pathologists. He was involved in research into hospital sepsis, rheumatic fever, and many other scientific fields. An expert fencer, he was the non-playing captain of a British Olympic Fencing Team and a witty raconteur. He had special regard for pathology trainees from less developed countries and worked strenuously to find them training places in the United Kingdom.
Gordon Signy Fellowships enable young pathologists from countries with limited resources to visit centers of renowned excellence in other countries and to learn laboratory techniques that will be of benefit to the services provided from their laboratories when they return home. These Fellowships consist of financial support and, from 1975 to 2013, forty-three young pathologists from 22 countries have received a Fellowship.
The World Pathology Foundation obtains its funds solely from gifts and donations from WASPaLM member societies and does not have specific fund raising appeals.
In 2014 the citizens of Islington borough, the place in which he lived, honored him with The Islington People's Plaque which was placed on the home in which he died in 1972. Pictured on the right by Dr. Signy's house on Alwyne Road are Dr. Signy's children (from left Adam Signy, Mark Signy [holding plaque], Michael Signy, and Ruth Davies).
Certificates are given to all Fellows who have completed their training and presented reports of their experiences. Any previous Fellows who have not received certificates and wish to have one should contact the Foundation.
Gordon Signy Applications for Training in 2018 are Now Closed
The information below applies to applications for training in 2019.
1. Aim: The aim of the Gordon Signy Fellowship is to promote the public safety and the public health by fostering the development of anatomic and clinical pathology in all aspects, especially in the developing countries.
2. Award Amounts and Payments: The Fellowship provides an award of US $5,000 payable in two installments, the first US $4,500 at the beginning of a period of study and US $500 upon receipt of Fellows' reports of their experiences (see item 11 below). For training periods exceeding 89 days and at the discretion of the Regents of the Fellowship, an award of up to US $7,500 may be provided.
3. Number of Fellowships: The number of Fellowships offered each year is decided by the Trustees. For 2019, two Fellowships are offered.
4. Fellowship Purpose: The Fellowship is to assist a young pathologist to travel to another country to learn special skills which will be of advantage when the Fellow returns to his or her own country. The award is not intended to support general training in pathology.
5. International scope: The Fellowship is open to pathologists from all countries.
6. Duration of Study: The duration of the study period is variable, but should be long enough to enable the applicant to acquire the skills proposed in the application.
7. Initial Training Completion and Country of Residence Requirements: Any pathologist:
a. who has completed his or her training in anatomical and/or clinical pathology or one of their branches prior to the beginning of their proposed fellowship training; and
b. who has completed training not more than 10 years prior to application deadline; and
c. who lives in his or her country of birth or permanent residence is eligible to apply for the Fellowship.
8. Training Location Requirement: Training must be in a country other than the applicant's own.
9. Return to Home Country Requirement: The applicant must undertake to return to his or her own country on completion of the proposed course of study.
10. Training Director Approval Requirement: Applicants must submit evidence that those under whom applicant is going to work approve the proposed course of study (letter of acceptance).
NOTE: A letter from the institution where the applicant proposes to study must either accompany the application or, if sent separately, be received by the application deadline (30 June 2018). The signed letter must state that the applicant has been accepted for study and that the proposed area of study and duration of study is acceptable.
11. Letter of Reference Requirement: Applicants must provide one signed letter of reference from a teacher, supervisor, mentor, faculty or other person who was part of their initial pathology training program.
12. Diploma and Certificate Requirement: Applicants must provide a copy of their Medical Degree and Certificate of Training. The copy may be a photocopy and need not be a certified copy from the medical school or training program.
13. Disclosure of Support Requirement: The applicant must disclose all other sources of support (personal, family, corporate, other fellowships and training awards and so on) that will provide funds for the proposed training.
14. Curriculum Vitae Requirement: Applicants must submit a curriculum vitae that includes their name and address, current employment, education, memberships in professional societies and organizations, appointments to health care staffs (e.g. medical staff of a hospital), research (if any) and publications (if any).
15. Report Requirement: At the conclusion of the program, the fellow must submit a short report to the World Pathology Foundation. The report will be published on the WASPaLM/WPF web site.
Award Selection and Announcements: The award will be made by the Trustees of the World Pathology Foundation on the advice of an international Board of Regents. Awards will be announced no later than 15 September 2017.
Board of Regents Considerations: In assessing the applications, the Board of Regents will consider the scientific and clinical merit of the application, the qualifications of the applicant, the value of the proposed study to the applicant, and the value of the proposed study to the applicant's community. Other sources of income may be held at the same time as the Fellowship, but in making their recommendation the Board of Regents will consider the financial need of the applicant.
Retrospective Award Prohibited: The Board of the Trustees will not award a Fellowship to support a course of study already completed. Trainees already undertaking training, or about to do so, are not eligible to apply for a Gordon Signy Fellowship.
Applications are currently being accepted for training beginning on or after 1 January 2018 and ending no later than 31 December 2018. Applications must be received by 30 June 2018. Applicants must have completed their initial pathology training prior to the beginning of their proposed fellowship training. If applicants have not completed their initial pathology training prior to the current application date (30 June 2017), the applicant MUST submit documentation of the completion of initial training before funds can be provided for the Fellowship.
Application Forms: You may complete the forms using one of the formats below. The PDF FORM format is designed to be completed on a computer, saved, printed and then mailed and emailed. The PDF-TEXT ONLY format can only be printed. It can then be filled out by hand, copied or scanned and mailed/emailed. The TEXT form may also be scanned and then completed on a computer. The forms contain all the information needed for completion of the application including the email and postal (airmail) addresses to which they must be sent.
Additional Forms to Assist You: In addition to the Application Forms, we have included a suggested format for the curriculum vitae and a checklist form to assist you in making sure your application is complete. You are free to use any format you wish for your curriculum vitae as long as the information contained in the suggested format is present.
If you have any questions, please contact the administrative office listed on the forms themselves.
Please choose the application format that best suits your needs.
Please download or copy the forms below to assist you in preparing your application.
Gordon Signy Fellowship Awardees
|1975||Ponnu Goundar||Suva, Fiji||Frozen Sections||New Zealand|
|1979||S.E. Ikerionwu||Nigeria||Cytogenetics||U of Minnesota, USA|
|1981||Raj Mehrota||India||Liver Pathology||London, UK|
|1981||Victor K.E. Lim||Malaysia||Microbiology||UK|
|1981||Samir Sami Amr||Jordan||Liver & Kidney Path||Washington DC, USA|
|1982||Tivaadar Laszio Miko||Hungary||Stomatology||London, UK|
|1983||Ho-Cheong-Ho||Hong Kong||Neuropathology||Southampton, UK|
|1984||Milan Simic||Yugoslavia||Sudden death/drug abuse||Karolinska Hospital, SWE|
|1984||Zhu Simin||PR China||Immunopathology||Not Recorded|
|1987||Zhang Xin-Min||PR China||Soft Tissue Pathology||Toronto, CA|
|1987||Chi-Sing Ng||Hong Kong||Southern Blot Analysis||Toronto, CA|
|1989||Mmari Mirisho-Pente Wilson||Tanzania||Hemoglobinopathies||Univ Coll, London, UK|
|1989||Kin-hang Fu||Hong Kong||DNA Hybridization||Childrens Hosp, Vancouver, CA|
|1989||Kamthorn Thramprasert||Thailand||Kidney, Skin and cytologic pathology||Royal Melbourne Hospital, AU|
|1990||Venkatesh Murthy Sashidhar||India||Laboratory Quality Control||Loma Linda Univ Hosp, California, USA|
|1990||S. Bijur||India||Not Recorded||Not Recorded|
|1991||Sa Gilda Da Cunha Santos||Brazil||Fine needle aspiration biopsy||Karolinska Hospital, SWE|
|1993-4||A. Banjo||Nigeria||Cytopathology and Genetics||St. Mary's, London, UK|
|1993-4||B. Jafari||Iran||Fine needle aspiration biopsy||Toronto General, CA and Johns Hopkins, USA|
|1995-6||R. Makunike||Zimbabwe||Fine needle aspiration biopsy||Institute for Cancer Research, Oslo, SWE|
|1995-6||Angela Flavia Loguelo||Brazil||Head and neck tumors||Memorial Sloan Kettering, NY, USA|
|1996-7||Dr. Turgan||Turkey||Not Recorded||Not Recorded|
|1996-7||Dr. Popovska||Bulgaria||Not Recorded||Not Recorded|
|1996-7||Dr. Yazdanipour||Iran||Declined Award||No reason given|
|1997-8||Dr. Guevera-Pineda||Peru||Not Recorded||Not Recorded|
|1997-8||Dr. Pinto||Brazil||Not Recorded||Not Recorded|
|1999||Obiageli Eunice Nnodu||Nigeria||Fine needle aspiration biopsy||Not Recorded|
|2000||M. Olufemi Dada||Nigeria||Hematology||Kings College Hospital, London, UK|
|2001||Isin Soyuer||Turkey||Cytopathology||MD Anderson Cancer Institute, USA|
|2001||Jorge Sergio Reis Filho||Brazil||Breast pathology||Robbins Breast Cancer Research Center, London, UK|
|2002||Giedrius Salkus||Lithuania||Molecular and soft tissue pathology||Brigham & Women's, Boston, USA|
|2002||Perera Rajeeka Lakmalee Morawakage||Sri Lanka||Tissue Typing||North London Blood Center, UK|
|2002||Gabriel Oladiyi Ogun||Nigeria||Bone Tumors||Armed Forces Institute of Pathology, USA|
|2003||Smita Chowkekar||India||Dermatopathology||Ackerman Academy, New York, USA|
|2003||Narantsatsralt Narantsogt||Mongolia||Molecular Medicine||Tokai University, Japan|
|2003||Ceyda Kabaroglu||Turkey||Gas Chromatography; Mass Spectroscopy||VU University, Amsterdam, Netherlands|
|2004||Rashmi Tondon||India||Platelets||Cambridge & Bristol, UK|
|2004||Isabela Werneck Cunha||Brazil||Bone and soft tissue||Mayo Clinic, USA|
|2004||Teklu Legesse||Ethiopia||Declined Award||Death in Family|
|2005||Antonio Hugo Jose Froes Marques Campos||Brazil||Hematologic malignancies||Centro Nacional de Investigaciounes Oncologicas Molecular Pathology Programme, Spain|
|2005||Leticia Gresta||Brazil||Soft tissue pathology||Mayo Clinic, USA|
|2005||Aline Helen Da Silva||Brazil||Neuropathology & Hematopathology||University of California, Los Angeles, USA|
|2006||Rajalakshmi Tirumalae||India||Molecular dermatopathology||Dermatologikum, Hamburg, Germany|
|2007||Cristovam Scapulatempo Neto||Brazil||Urologic Pathology||Johns Hopkins, USA|
|2007||Joseph Marie Mendimi Nkodo||Cameroon||Cytopathology||Hospital Lariboisiere, Paris, France|
|2008||Alexandre Nakao Odashiro||Brazil||Not Recorded||Not Recorded|
|2009||No Award||No Award||No Award||No Award|
|2010||Jha Runa||Nepal||Hematology||Chandigarh, India|
|2011||Carlos Augusto Moreira Silva||Brazil||Hematopathology||Barcelona Clinic Hospital, Barcelona, Spain|
|2012||No Award||No Award||No Award||No Award|
|2013||D'Almeida Costa||Brazil||Neuropathology||Johns Hopkins, USA|
|2013||Henry Okuchukwu Ebili||Nigeria||Declined Award||No reason given|
|2014||Julio Diaz-Perez||Columbia||Dermatopathology||Wake Forest, USA|
|2014||Medina Rajbhandari||Nepal||Breast Pathology||Istituto di Ricovero e Cura a Carattere Scientifico, Turin, Italy|
|2015||Leonardo Lordello||Brazil||Gynecologic Pathology||Massachusetts General Hospital, USA|
|2015||Panjwani Poonam||India||Hematopathology||Stanford University, USA|
|2016||Geise Rezende Paiva||Brazil||Melanoma||Brigham and Women's Hospital, Boston USA|
|2016||EsperanÃ§a da Paz Ussene||Mozambique||Neuropathology; fetal pathology||Centro Hospitalar Lisboa Ocidental-Hospital Egas Moniz, Portugal|
|2017||Ademola Samson Adewoyin||Nigeria||Hematopathology||Duke University, USA|
|2017||Pedro Henrique Pinto||Brazil||Hematology and Molecular Pathology||Instituto de Investigación Sanitaria – Fundación Jiménez Díaz / Madrid – Spain|